If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCheckit Regulatory News (CKT)

Share Price Information for Checkit (CKT)

Share Price is delayed by 15 minutes
Get Live Data
21.50    0.00 (0.00%)
Bid:
21.00
Ask:
22.00
Spread: 1.00 (4.762%)
Market Cap: £23.22m
CKT Live PriceLast checked at - London Stock Exchange

Intraday Checkit Share Chart

Contract Wins

12 Jun 2024 07:00

RNS Number : 0440S
Checkit PLC
12 June 2024
 

12 June 2024

 

Checkit plc

("Checkit" or the "Group")

 

Contract Wins

 

Checkit (AIM: CKT), the automated monitoring platform for operational leaders, is pleased to announce a significant expansion with an existing US customer and a first customer for the recently launched AI module.

 

Contract Wins

 

The Group announces a significant expansion with Octaphama Plasma in the United States worth c.£718,000 over three years.

 

Octapharma will be expanding their use of the Checkit platform by integrating TTMUs (Tactical Temperature Monitoring Units) into their existing monitoring system, further protecting their operational data and mission-critical inventory. By leveraging the TTMUs offline data logging capabilities, Octapharma will have complete data redundancy across their entire network of plasma donation centres in the US. The investment highlights Octapharma's ongoing commitment to ensuring the safety and security of their plasma and operational data.

 

The Group is also pleased to announce a first signed contract for the recently launched Asset Intelligence product module, which applies advanced analytics and Machine Learning to IoT data which will help enhance customer sustainability, reduce costs, and improve revenue.

 

Commenting on the news Kit Kyte, Chief Executive Officer, said: "This latest win continues to validate our 'land and expand' strategy and demonstrates continued momentum in the US, a strategic priority for the business. Forward-thinking leaders like Octapharma understand why it's so critical to execute an operational data strategy, and we appreciate their trust and partnership. I am also thrilled that we have secured our first customer for the recently launched Asset Intelligence module, which marks the start of an exciting chapter in the evolution of our offering and our integrated end-to-end platform."

 

For further information, please visit www.checkit.net or contact:

 

Checkit plc

Kit Kyte (Chief Executive Officer)

Greg Price (Chief Financial and Operations Officer)

+44 (0) 1223 643313

Singer Capital Markets (Nominated Adviser & Broker)

Shaun Dobson / Peter Steel / James Fischer

+44 (0) 20 7496 3000

Tavistock (Financial PR)

Lulu Bridges / Katie Hopkins / Simon Hudson

+44 (0) 20 7920 3150

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
CNTFLFITRLILLIS
Date   Source Headline
25th Jun 20145:42 pmRNSHolding(s) in Company
23rd Jun 20147:00 amRNSPlacing and Proposed Open Offer
23rd Jun 20147:00 amRNSUnaudited full year results
20th Jun 20147:00 amRNSConclusion of Strategic Alternatives Process
17th Jun 20147:00 amRNSStatement regarding Elektron Technology plc
2nd Jun 20145:33 pmRNSForm 8 (OPD) Microgen plc
2nd Jun 201412:35 pmRNSForm 8.3 - [Microgen Plc]
27th May 20142:10 pmRNSStatement re Elektron Technology Plc
21st May 20149:00 amRNSResponse to Microgen
20th May 201412:39 pmRNSFurther Statement Re Elektron Technology Plc
20th May 201410:20 amRNSStatement re Elektron Technology
13th May 20143:20 pmRNSStrategic Alternatives Process Update
29th Apr 201410:09 amRNSHolding(s) in Company - Replacement
25th Apr 20142:03 pmRNSForm 8.3 - Elektron Technology Plc
25th Apr 20141:45 pmRNSForm 8 (DD) - [Elektron Technology PLC]
23rd Apr 20145:32 pmRNSForm 8.3 - [Elektron Technology Plc]
23rd Apr 20143:22 pmRNSForm 8.3 - [Elektron Technology]
23rd Apr 20143:15 pmPRNForm 8.3 - Elektron Technology Plc
23rd Apr 201410:37 amRNSForm 8.3 - [ELEKTRON TECHNOLOGY PLC] Amendment
23rd Apr 20149:00 amRNSHolding(s) in Company
23rd Apr 20147:00 amRNSForm 8 (OPD) (Elektron Technology plc)
22nd Apr 201411:16 amRNSForm 8.3 - Elektron Technology PLC
22nd Apr 20149:32 amRNSForm 8.3 - Elektron Technology PLC
22nd Apr 20147:59 amRNSForm 8.3 - Elektron Technology plc
17th Apr 201411:03 amRNSForm 8.3 - Elektron Technology plc
17th Apr 20148:05 amRNSStrategic Alternatives Process Update
16th Apr 20141:41 pmRNSForm 8.3 - Elektron Technology PLC
16th Apr 201412:29 pmRNSForm 8.3 - Elektron Technology PLC
15th Apr 201412:22 pmRNSForm 8.3 - Elektron Technology Plc
15th Apr 201412:17 pmRNSForm 8.3 - Elektron Technology Plc
15th Apr 201412:05 pmRNSForm 8.3 - Elektron Technology Plc
15th Apr 201411:52 amRNSForm 8.3 - Elektron Technology Plc
15th Apr 20147:59 amRNSForm 8.3 - Elektron Technology plc
14th Apr 20141:42 pmRNSForm 8.3 - Elektron Technology plc
9th Apr 20141:38 pmRNSForm 8.3 - Elektron Technology Plc
9th Apr 201412:03 pmRNSForm 8.3 - ELEKTRON TECHNOLOGY PLC
8th Apr 20146:20 pmBUSForm 8.3 - ELEKTRON TECHNOLOGY PLC - Amendment
8th Apr 20143:07 pmRNSAppointment of CFO
8th Apr 20143:06 pmRNSForm 8.3 - Elektron Technology PLC
8th Apr 201412:59 pmBUSForm 8.3 - ELEKTRON TECHNOLOGY PLC
7th Apr 20143:20 pmRNSStrategic Alternatives Process & Offer Period
11th Feb 20147:00 amRNSYear end trading update
13th Jan 20147:00 amRNSDirectorate Change
17th Dec 20137:00 amRNSThird quarter trading update
4th Nov 20137:00 amRNSExit from China manufacturing
24th Oct 20137:00 amRNSDirector's Dealing
9th Oct 20137:00 amRNSDirectorate Change
12th Sep 20137:00 amRNSHalf Year Results
11th Sep 201310:36 amRNSHolding(s) in Company
30th Aug 20137:00 amRNSProduct Launch

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.